Author | Age (Years) | Sex | Manufacture | Dose (1st/2nd) | Time between vaccine and onset (days) | Presentation | Pathology | Treatment | Response |
---|---|---|---|---|---|---|---|---|---|
Gul Rahim | 52 | F | Pfizer | 2nd | < 1 | GH, AKI | N/A | None | Remission of GH in less than 1 week |
Negrea | 38 | F | Pfizer | 2nd | < 1 | GH, SRP | N/A | None | Remission of GH after 3 days |
38 | F | Pfizer | 2nd | < 1 | GH | N/A | None | Remission of GH after 3 days | |
Perrin | 22 | M | Moderna | 1st | 2 | GH | N/A | None | Remission of GH |
41 | F | Pfizer | 1st | 2 | GH | N/A | None | Remission of GH | |
27 | F | Pfizer | 2nd | 2 | GH | N/A | None | Remission of GH | |
Plasse | N/A | N/A | Pfizer | 2nd | 5 to 6 | GH, SRP, AKI | N/A | Corticosteroids | Remission of GH, AKI after 1 month, SRP within 2 months |
N/A | N/A | Pfizer | 2nd | 1 | GH | N/A | None | Remission of GH after 3 days | |
This Case | 54 | F | Moderna | 2nd | 2 | GH, SRP, AKI | Active IgAN | Corticosteroids | Remission of GH after 2 days, AKI in 3 months |